<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Harvard Law School Forum on Corporate Governance</title>
	<atom:link href="https://corpgov.law.harvard.edu/2020/09/08/esg-didnt-immunize-stocks-against-the-covid-19-market-crash/feed/" rel="self" type="application/rss+xml" />
	<link>https://corpgov.law.harvard.edu</link>
	<description>The leading online blog in the fields of corporate governance and financial regulation.</description>
	<lastBuildDate>Sat, 25 Apr 2026 11:30:57 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.5.8</generator>

<image>
	<url>https://corpgov.law.harvard.edu/wp-content/uploads/2024/02/cropped-photography-4-e1706898544564-1-32x32.png</url>
	<title>ESG Didn’t Immunize Stocks Against the Covid-19 Market Crash &#8211; The Harvard Law School Forum on Corporate Governance</title>
	<link>https://corpgov.law.harvard.edu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>ESG Didn’t Immunize Stocks Against the Covid-19 Market Crash</title>
		<link>https://corpgov.law.harvard.edu/2020/09/08/esg-didnt-immunize-stocks-against-the-covid-19-market-crash/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=esg-didnt-immunize-stocks-against-the-covid-19-market-crash</link>
		<comments>https://corpgov.law.harvard.edu/2020/09/08/esg-didnt-immunize-stocks-against-the-covid-19-market-crash/#comments</comments>
		<pubDate>Tue, 08 Sep 2020 13:37:06 +0000</pubDate>
<!-- 		<dc:creator><![CDATA[]]></dc:creator> -->
				<category><![CDATA[Academic Research]]></category>
		<category><![CDATA[Corporate Social Responsibility]]></category>
		<category><![CDATA[Empirical Research]]></category>
		<category><![CDATA[ESG]]></category>
		<category><![CDATA[Financial Crisis]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[Financial crisis]]></category>
		<category><![CDATA[Firm performance]]></category>
		<category><![CDATA[Market conditions]]></category>
		<category><![CDATA[Shareholder value]]></category>
		<category><![CDATA[Stock returns]]></category>

		<guid isPermaLink="false">https://corpgov.law.harvard.edu/?p=132673?d=20200908093706EDT</guid>
		<description><![CDATA[From its high on February 19th, 2020, the S&#38;P 500 index lost more than one-third of its value in a little over a month as the potential human and economic consequences of the global pandemic began to be incorporated into share prices. In the wake of this COVID-19-induced stock pummeling, there were widespread claims being [&#8230;]]]></description>
				<content:encoded><![CDATA[<hgroup><em>Posted by Elizabeth Demers (University of Waterloo), on Tuesday, September 8, 2020 </em><div class='e_n' style='background:#F8F8F8;padding:10px;margin-top:5px;margin-bottom:10px;text-indent:2.5em;'><strong style='margin-left:-2.5em;'>Editor's Note: </strong> <p style="margin:0; display:inline;"><a href="https://uwaterloo.ca/school-of-accounting-and-finance/people-profiles/elizabeth-demers">Elizabeth Demers</a> is Professor at the University of Waterloo School of Accounting and Finance. This post is based on a recent <a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3675920">paper</a> by Professor Demers; Jurian Hendrikse, Master&#8217;s student at Tilburg University; <a href="https://www.tilburguniversity.edu/staff/philjoos">Philip Joos</a>, Professor at Tilburg School of Economics and Management; and <a href="https://www.stern.nyu.edu/faculty/bio/baruch-lev">Baruch Lev</a>, Philip Bardes Professor of Accounting and Finance at the New York University Stern School of Business. Related research from the Program on Corporate Governance includes <a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3544978">The Illusory Promise of Stakeholder Governance</a> by Lucian A. Bebchuk and Roberto Tallarita (discussed on the Forum <a href="https://corpgov.law.harvard.edu/2020/03/02/the-illusory-promise-of-stakeholder-governance/">here</a>); <a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2464561">Socially Responsible Firms</a> by Alan Ferrell, Hao Liang, and Luc Renneboog (discussed on the Forum <a href="https://corpgov.law.harvard.edu/2014/08/06/socially-responsible-firms/">here</a>); and <a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3677155">For Whom Corporate Leaders Bargain</a> by Lucian A. Bebchuk, Kobi Kastiel, and Roberto Tallarita (discussed on the Forum <a href="https://corpgov.law.harvard.edu/2020/08/25/for-whom-corporate-leaders-bargain/">here</a>).</p>
</div></hgroup><p>From its high on February 19<sup>th</sup>, 2020, the S&amp;P 500 index lost more than one-third of its value in a little over a month as the potential human and economic consequences of the global pandemic began to be incorporated into share prices. In the wake of this COVID-19-induced stock pummeling, there were widespread claims being made by large investors and fund managers (such as Blackrock, Morningstar), purveyors of ESG data (such as MSCI), as well as by the financial press (including Fortune, the Financial Times, and the Wall Street Journal) that companies with higher environmental, social, and governance (“ESG”) performance scores were immunized against the pandemic-induced value destruction.</p>
<p>The notion that ESG activities contribute to stock price resilience during periods of crisis is premised upon the belief that corporate social responsibility activities help to build social capital and trust in the corporation. These bonds, the story goes, will motivate the company’s stakeholders (employees, customers, suppliers, financiers, government, society, etc.) to help the firm weather the challenges imposed by a crisis. Indeed, several studies of the 2008-2009 global financial crisis (“GFC”) purport to provide evidence of such downside risk protection. An alternative view of corporate social responsibility suggests that executives may choose to improve their company’s ESG scores at the expense of shareholders in order to build their own personal reputation. From this agency theory perspective, ESG investments are at best wasteful, and probably even harmful to shareholders (e.g., by increasing the propensity for management entrenchment). To the extent that investments in corporate social responsibility reflect poor management and/or agency problems, higher ESG scores could be an indication of potential hindrances to the firm’s resilience during challenging times. So which is it? Our <a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3675920">study</a> undertakes an extensive set of analyses in order to address this question in the context of U.S. equities during the current global pandemic.</p>
<p> <a href="https://corpgov.law.harvard.edu/2020/09/08/esg-didnt-immunize-stocks-against-the-covid-19-market-crash/#more-132673" class="more-link"><span aria-label="Continue reading ESG Didn’t Immunize Stocks Against the Covid-19 Market Crash">(more&hellip;)</span></a></p>
]]></content:encoded>
			<wfw:commentRss>https://corpgov.law.harvard.edu/2020/09/08/esg-didnt-immunize-stocks-against-the-covid-19-market-crash/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>
